Quick answer
What are the three vWD1 genetic test categories?
Clear (no copies), carrier (one copy), and affected (two copies), with vWD1's incomplete dominance meaning carriers can show some mild clotting factor reduction, unlike a typical simple recessive trait.
A vWD1 result on a health certificate uses precise genetic language, clear, unaffected, carrier, affected, and each word changes what a responsible next step actually is.
This affects breeders planning pairings, and puppy buyers trying to read a breeder's health testing paperwork and understand whether a parent's carrier status is something to worry about or simply something to know.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
Von Willebrand's disease Type 1 genetic testing sorts dogs into clear, carrier, and affected categories, but because the condition shows incomplete dominance, a carrier is not automatically symptom-free the way a carrier of a simple recessive trait would be. Understanding this distinction matters most for breeders making pairing decisions and buyers reading a breeder's health testing paperwork.
vWD1 carrier and affected status both appear on genetic panels for this breed at rates that make testing a standard, expected part of responsible breeding practice rather than a rare or unusual finding.
The Bichon Frise is a breed in which the vWD1 variant is documented and tested for on standard genetic panels. Its incomplete dominance inheritance pattern is a feature of the variant itself rather than anything breed-specific, but the breed's overall limited founding gene pool makes the variant more likely to appear across the population than in a breed with broader genetic diversity.
Breeding decisions, not environment, are the primary factor that determines how this variant is passed to future generations. Testing availability and how consistently breeders use it also shape how well-managed the variant is within the broader breed population.
Talk to your vet about interpreting a specific test result, whether carrier or affected, particularly before any planned breeding or before a puppy's first surgery, since the practical implications differ by category and by individual dog.
See all Bichon Frise health problems, which breeds are prone to von willebrands disease vwd1, or the full Bichon Frise breed guide for temperament, exercise needs and ownership costs.
Genetic testing results are typically available within one to three weeks of sample submission, and the information they provide is permanent, not something that needs repeat testing over a dog's lifetime.
Success looks like informed pairing decisions for breeders and a clear understanding for buyers, not the complete elimination of the variant from the breed, which is not a realistic goal given the population's genetic background.
Von Willebrand's disease Type 1 follows an autosomal inheritance pattern with incomplete dominance, meaning a dog's status depends on how many copies of the variant it carries, one from each parent. A dog with zero copies is genetically clear. A dog with one copy is a carrier, which in this particular form of the disease often means some reduction in clotting factor, milder than a dog with two copies but not necessarily identical to a fully clear dog. A dog with two copies is affected, with the most significant reduction in von Willebrand factor and the highest bleeding risk of the three categories.
This is different from a simple recessive trait where carriers are unaffected. In vWD1, carrier status can carry some real, if usually mild, clinical relevance, which is exactly why breeders and vets treat it as a spectrum rather than a strict affected-or-not binary.
Pairing two carriers, or a carrier with an affected dog, statistically increases the chance of producing affected puppies in that specific litter, since each parent can pass along a copy of the variant. Pairing a carrier with a genetically clear dog avoids producing any affected puppies from that litter, though it can still produce carrier puppies. Responsible breeding with this condition in mind is not about only ever using clear dogs, since that would badly narrow an already limited gene pool in a small-population breed, but about knowing each parent's status and choosing pairings that manage, rather than concentrate, the risk.
A puppy buyer seeing "carrier" on a parent's vWD1 result should not read that as a red flag disqualifying the breeder. It is a transparent, useful disclosure. What matters more is whether the breeder tested at all, whether they can explain what the result means for the specific puppies in that litter, and whether the puppy itself has been or will be tested before any future surgery. A breeder who tests and discloses honestly, even with a carrier result, is demonstrating exactly the kind of practice a buyer should want, regardless of what the specific result says.
If you think your Bichon has von willebrand's disease (vwd1), the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers skin allergies, patellar luxation, bladder stones.
What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.
Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for von willebrand's disease (vwd1) it is often what separates a clear pattern from a guess.
Reba's breeder had two promising females she wanted to pair with the same stud dog for an upcoming litter, and vWD1 testing on all three came back with one female as a carrier and the stud dog also a carrier, a pairing that would have meaningfully raised the chance of affected puppies. Rather than proceeding as planned, the breeder paired the carrier female with a different, genetically clear stud instead, and used the original stud with her other, clear female. Both litters were tested as puppies, with clear and carrier results distributed as expected and no affected puppies in either litter. Reba herself came from the clear-to-clear pairing, and her paperwork noted her own clear vWD1 status clearly for her eventual buyer, a straightforward, unremarkable result made possible by a pairing decision made carefully in advance.
Key takeaway: Genetic test results only protect a breed's health when they actually change pairing decisions, and knowing both parents' vWD1 status before finalizing a litter is what turns a test result into a meaningful safeguard rather than paperwork.
It means the dog has one copy of the variant. Because vWD1 shows incomplete dominance, a carrier may have some mild reduction in clotting factor, though usually less pronounced than a dog with two copies who is classified as affected.
It increases the statistical chance of producing affected puppies in that litter, since each parent can pass along a copy. It is not automatically disqualifying, but it is a pairing that calls for informed discussion and, ideally, testing the resulting puppies.
Not necessarily. Carrier disclosure reflects transparent testing practice. What matters more is whether the specific puppy has been or will be tested, and whether the breeder can explain the result clearly.
No. An affected dog has two copies of the variant and typically the most significant reduction in clotting factor. A carrier has one copy and, due to the condition's incomplete dominance, may show a milder effect or sometimes none clinically.
In a breed with an already limited gene pool, restricting breeding to only clear dogs for every known variant would narrow genetic diversity further and is not considered responsible practice on its own. Managed pairings, informed by testing, are the more sustainable approach.
Discuss it with your vet, particularly before any planned surgery. Some carriers show mild clotting factor reduction worth being aware of during procedures, even though many live with no noticeable day-to-day effect.
Clear (no copies), carrier (one copy), and affected (two copies), with vWD1's incomplete dominance meaning carriers can show some mild clotting factor reduction, unlike a typical simple recessive trait.
It increases the statistical chance of affected puppies in that litter and calls for informed pairing decisions, though it is not automatically disqualifying given the breed's limited gene pool.
No, transparent disclosure of a carrier result reflects responsible testing practice. What matters more is whether the specific puppy has been tested and the breeder can explain the result.
Because vWD1 follows an incomplete dominance pattern rather than simple recessive inheritance, a single copy of the variant can still produce some reduction in clotting factor.
Pair carriers with genetically clear dogs where possible to avoid producing affected puppies, and test resulting puppies rather than avoiding carriers from breeding programs entirely.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.
